An observational study in Sepsis, sponsored by University Hospital Southampton NHS Foundation Trust. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-02.
Sponsored by University Hospital Southampton NHS Foundation Trust · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 95 studies in Sepsis with a site in United Kingdom — 14 open to participants now, 14 under way, 1 of them phase 3. Sepsis · United Kingdom.
Among the 95 studies in Sepsis with a site in United Kingdom, this one is the 37th largest by planned enrollment of the 49 observational ones that give a count, is one of 5 that started in 2024, is one of 49 observational ones, reaches primary completion later than 2 of the 13 other live ones, and was the 88th registered.
2,425 studies on the registry are indexed under Sepsis; 543 are open to participants now.
Browse Sepsis studies →14 of the 95 studies in Sepsis with a site in United Kingdom are open now. Recruiting first, the newest first:
AstraZeneca · Sites in United Kingdom, United States, Argentina and 11 more countries
Ages 18–80
Liverpool University Hospitals NHS Foundation Trust · Sites in United Kingdom
Ages 18+
Royal Surrey County Hospital NHS Foundation Trust · Sites in United Kingdom
Ages 18+ · Healthy volunteers
NHS Greater Glasgow and Clyde · Sites in United Kingdom
Ages 18+
Imperial College London · Sites in United Kingdom
Ages 18+
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
95 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 4 · Phase 2 12 · Phase 3 18 · Phase 4 4
First in 2002; this study’s year is marked. 5 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 60 is below the median of 150 across 1,166 observational studies indexed under Sepsis.
Median enrollment 215 across the 45 interventional studies, 180 across the 49 observational. Of the 58 that completed or were terminated, 12 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
27 of 95 have an industry lead sponsor. The 10 most frequent:
University Hospital Southampton NHS Foundation Trust is the lead sponsor of 150 studies on the registry; 35 are open to participants now.
University Hospital Southampton NHS Foundation Trust has 2 studies filed under Sepsis — fewer than ten, so there is no comparison to draw.
5 of the studies in Sepsis with a site in United Kingdom that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05179499Phase 3NHS Greater Glasgow and ClydeEarly Vasopressors in Sepsis | 2026-11 |
| NCT07215702AstraZenecaA Study to Investigate the Efficacy, Safety, and Tolerability of AZD4144in Participants With Sepsis-associated Acute Kidney Injury. | 2027-02-11 |
| NCT05647096Santersus AGSafety, Tolerability and Performance of the NucleoCapture Device in the Reduction of Circulating CfDNA/NETs in Subjects with Sepsis | 2027-05-05 |
| NCT06977165University of ManchesterInvestigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis | 2027-06-30 |
| NCT07131969University of CambridgeTranscriptional Analysis of Mechanisms in Liver Failure and Sepsis | 2027-09 |
Add all 5 to your calendar (.ics) → With an account.
Among the 95 studies in Sepsis with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to determine whether additional investigations used in other parts of healthcare can be used in the Emergency Department to identify critically ill patients quicker than usual care.
The investigators intend to recruit 56 patients with suspected sepsis who attend the Emergency Department. The investigators want to use a device to monitor tissue oxygen levels when they first come into the Emergency Department as well as the change in tissue oxygen levels when a tourniquet is applied for 3 minutes. The investigators will take novel blood tests when the patient is having their routine bloods. Finally, the investigators will use a special camera to take specialised pictures of the small blood vessels under the tongue which will show blood flow through these vessels. The investigators will follow the recruited patients and determine if our extra data is better at determining who needs critical care. A significant proportion of patients may be too unwell or too distressed to consent to be part of this study. At the earliest opportunity, the investigators will ask patients when they have been stabilised and are able to give consent. If they say no, they will be removed from the study and their care will not be affected by this decision.
The results could help us identify septic shock as early as possible so that these unwell patients are identified early and get the correct treatment they need. This could mean starting advanced treatments usually found in the Intensive Care Unit very early on in a patient's journey.
Adult patients presenting to the Emergency Department with their illness possibly caused by sepsis
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Critical care therapies-initiated pre-hospital. Critical care therapies defined as:
4.1 Mechanical ventilation 4.2 Vasopressor/inotrope therapy 4.3 Sedation or a general anaesthetic 4.4 Pre-hospital transfusion of blood products 4.5 Extra-corporeal support
Patients who present with potential sepsis. This is characterised by their illness suspected to be from an infection and significantly unwell defined by one of two scoring systems, either the National Early Warning Score or quick Sequential Organ Failure Assessment
Diagnostic Test: Measuring tissue oxygenation · Diagnostic Test: Procalcitonin · Diagnostic Test: Mid-regional proadrenomedullin · Diagnostic Test: Hand-held video microscope
Measuring oxygen content of arteries, capillaries and veins
Blood test
Also known as: PCT
Blood test looking at inflammation in the body
Also known as: MR-proADM
A handheld video microscope that looks at blood flow through the capillaries of the tongue
Differences in tissue oxygenation
The difference in tissue oxygen saturation (StO2) during the vascular occlusion test in the Emergency Department between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured in % change per second..
Time frame: Up to 4 hours (from baseline); 28 days (follow-up)
Baseline of tissue oxygenation
The difference in tissue oxygen saturation (StO2) at baseline in the Emergency Department between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured in %.
Time frame: Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood flow of the micro-circulation (microvascular flow index)
Differences in the flow of blood through small blood vessels underneath the tongue between the difference between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured by the Microvascular Flow Index (arbitrary units) which is a validated measurement assessing micro-circulatory flow.
Time frame: Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood flow of the micro-circulation (perfused vessel density)
Differences in the flow of blood through small blood vessels underneath the tongue between the difference between septic patients who need critical care treatment (CCT) compared to patients requiring ward care. This will be measured by the perfused vessel density (measured in mm/mm2) which is a validated measurement assessing micro-circulatory flow.
Time frame: Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood lactate levels
The difference in the blood tests of lactate between septic patients who need critical care treatment (CCT) compared to patients requiring ward care
Time frame: Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood tests (MR-proADM)
The difference in the blood tests of MR-proADM between septic patients who need critical care treatment (CCT) compared to patients requiring ward care
Time frame: Up to 4 hours (from baseline); 28 days (follow-up)
Difference in blood tests (Procalcitonin)
The difference in the blood tests of Procalcitonin (PCT) between septic patients who need critical care treatment (CCT) compared to patients requiring ward care
Time frame: Up to 4 hours (from baseline); 28 days (follow-up)
Correlation of extra investigations with standard patient outcomes
Looking at whether tissue oxygenation, buccal microcirculation (blood flow under the tongue) and biomarkers and correlation with clinical outcomes such as organ failure (SOFA) scores, 28-day hospital mortality, and length of hospital and ICU stay.
Time frame: Up to 4 hours (from baseline); 28 days (follow-up)
Plan to share: Yes — Individual participant data (IPD) that underlie results in a publication will be shared
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: 6 months after publication
Started Jan 2024 (actual). Primary completion is estimated for Aug 2025, 18 months after the start.
Of 496 non-industry observational studies under Sepsis, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 57. This study's planned 18 months is below that.
Counting every sponsor, half of 548 studies reached it within 27 months; a quarter within 12 and three quarters within 55.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital Southampton NHS Foundation Trust →